News — Founders


Attending the Jefferies Healthcare Conference

We’re pleased to share that our co-founders Dr Lara Zibners and Thang Vo-Ta will be attending the Jefferies Healthcare Conference from 17–20 November 2025. We’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and …

5 Takeaways from the Milken Institute Women’s Health Network launch
Dr Lara Zibners
Co-founder & Chair

As a co-founder, you must jump at any chance you get to open the doors that will carry you to the finish line. It might have been crazy, but a 24-hour trip to Columbus, Ohio in September led to an introduction to Ayodola Anise from the Milken Institute Women’s Health Network. That led to an …

ASRM Scientific Congress & Expo
Thang Vo-Ta
Co-founder & CEO

It’s been a superb start here in San Antonio, TX 🇺🇸 at the American Society for Reproductive Medicine – Scientific Congress & Expo– with already so many inspiring conversations, new connections, and fresh learnings. 💡 A few early highlights include finally meeting Dr David Sable in person who delivered an outstanding Herbert H. Thomas MD …

On stage at HLTH Vegas

Amazing to see our co-founder Dr Lara Zibners on the main stage at HLTH Vegas: the largest healthcare innovation event of the year. 🌟 Her panel of women leaders explored how innovation and education are transforming hormone replacement therapy (HRT) — breaking barriers to access, tackling misinformation, and empowering women to take control of their …

The Inaugural Women’s Health Horizons
Dr Lara Zibners
Co-founder & Chair

And that’s a wrap! Women’s Health Horizons (WHH) was amazing! Starting with my fellow advisory board members (all of whom are total ballers), followed by Day 1 of panels, keynotes and workshops and even a bit of mindfulness. This morning was a powerful summary of the day before with a call to action to break …

Dr Zibners joins Women’s Health Horizons Advisory Board

🌟 Introducing Dr. Lara Zibners, Our Strategic Advisory Board Member 🌟 We’re proud to welcome Dr. Lara Zibners to Women’s Health Horizons (WHH)’s Strategic Advisory Board. Dr. Zibners will be attending our Boston conference on 15-16 October 2025 at the Hyatt Regency Boston / Cambridge. Dr. Zibners is a leading voice in women’s health, trauma …

At the Milken Asia Summit 2025
Thang Vo-Ta
Co-founder & CEO

It was a real privilege to be part of the Milken Institute Asia Summit 2025 in Singapore 🇸🇬 . Under this year’s theme of “Progress with Purpose,” it was inspiring to hear and engage with leaders in so many different fields tackling the mega trends shaping the region. I was especially encouraged by the focus …

Society of Physician Entrepreneurs event with Dr Lara Zibners
McCarter & English LLP
265 Franklin Street
Boston MA 02110

McCarter & English, LLP will host the Society of Physician Entrepreneurs on Oct 16th 2025 for a discussion with Dr. Lara Zibners, pediatric emergency medicine physician, published author, trauma educator and entrepreneur. Lara is the co-founder of Calla Lily Clinical Care, a UK based B-corp revolutionizing vaginal drug delivery. Read more: https://lnkd.in/g-YbahS4

From Stigma to Solutions: Int’l Insights on Pregnancy Loss
Dr Lara Zibners
Co-founder & Chair

Pregnancy loss care is changing, but there’s still so much work to do. Next week on October 8, join me for a panel hosted by WHIC – Womens Health Innovation Council as we explore what’s missing, what’s evolving, and what’s next in this often-overlooked area of women’s health. We’ll bring together clinical insights, emotional support …

34th Singapore Pharmacy Congress
Thang Vo-Ta
Co-founder & CEO

Grateful for a superb two days back home at the 34th Singapore Pharmacy Congress 🇸🇬  a fantastic gathering of clinical leaders, innovators, and pharmacists committed to advancing patient care. It was a privilege to present our user-centric Callavid® vaginal drug delivery platform designed to address the anxiety, discomfort, and low adherence often associated with outdated …